导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -9.81% | 3732/4773 |
| 近一周 | -2.13% | 1294/5462 |
| 近一月 | -1.35% | 923/5421 |
| 近一季 | -4.37% | 1611/5209 |
| 近半年 | -7.69% | 3255/4920 |
| 近一年 | -7.24% | 3217/4366 |
| 近两年 | 29.98% | 2268/2954 |
| 近三年 | 23.47% | 1343/2253 |
| 成立以来 | 50.15% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.52% 4302/4961 |
1.86% 2984/5312 |
- - |
- - |
| 2025 | 14.87% 2586/4813 |
4.91% 863/3635 |
-4.94% 3522/4076 |
14.38% 2912/4524 |
0.71% 1825/4813 |
| 2024 | 23.73% 322/3463 |
6.28% 301/2808 |
-0.87% 856/3014 |
16.14% 1524/3129 |
1.12% 1118/3463 |
| 2023 | 4.71% 219/2656 |
9.27% 418/2280 |
5.05% 75/2385 |
-4.45% 1142/2515 |
-4.54% 1081/2655 |
| 2022 | -19.40% 844/2207 |
-20.28% 1532/1919 |
15.51% 169/2016 |
-10.98% 480/2113 |
-1.67% 1724/2208 |
| 2021 | -8.90% 1062/1822 |
-0.67% 381/1255 |
2.38% 1005/1330 |
-15.80% 1392/1466 |
6.40% 219/1822 |
| 2020 | - - |
- - |
- - |
8.93% 690/1164 |
15.71% 196/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 国泰中证全指家用电器ETF联接C VS. 长安沪深300非周期A(740101) |